Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial. (Q40278537)
Jump to navigation
Jump to search
scientific article published on 31 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial. |
scientific article published on 31 July 2012 |
Statements
Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial (English)
Satoru Watanabe
Cynthia Sung
Fan Lu
Yok Moi Khoo
John Connolly
Jenny Low
How Sung Lee
Subhash G Vasudevan
31 July 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference